Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

v3.23.2
Net Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Anti-Dilutive Securities that Could Potentially be Dilutive in Future

The table below represents the anti-dilutive securities that could potentially be dilutive in the future for the periods presented:

 

 

As of June 30,

 

(in shares of common stock)

 

2023

 

 

2022

 

Stock options

 

 

1,088,704

 

 

 

1,915,529

 

Restricted stock units

 

 

18,215,964

 

 

 

15,013,114

 

FP Combination Warrants

 

 

8,291,704

 

 

 

8,291,704

 

Combination Warrants

 

 

2,763,902

 

 

 

2,763,902

 

Public Warrants

 

 

19,221,960

 

 

 

11,499,960

 

Private Placement Warrants

 

 

78,000

 

 

 

7,800,000

 

2027 Warrants

 

 

17,253,279

 

 

 

 

RDO Warrants

 

 

29,000,000

 

 

 

 

Placement Agent Warrants

 

 

2,030,000

 

 

 

 

PIPE Investment Obligation

 

 

13,750,000

 

 

 

4,912,664

 

Conversion Option Derivative

 

 

36,852,685

 

 

 

 

Schedule of Computations of Basic and Diluted Net Loss Per Share

The computations of basic and diluted net loss per share for the periods presented were as follows:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands, except per share and share amounts)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(28,130

)

 

$

(32,274

)

 

$

(82,575

)

 

$

(103,646

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average shares outstanding - basic and diluted

 

 

156,502,662

 

 

 

142,378,037

 

 

 

150,316,749

 

 

 

113,173,237

 

Net loss per share - basic and diluted

 

$

(0.18

)

 

$

(0.23

)

 

$

(0.55

)

 

$

(0.92

)